| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.95B | 34.80B | 35.42B | 34.09B | 31.29B | 29.83B |
| Gross Profit | 10.99B | 10.97B | 11.17B | 10.12B | 9.60B | 9.45B |
| EBITDA | 2.55B | 2.64B | 2.76B | 2.19B | 1.88B | 1.83B |
| Net Income | 1.23B | 1.29B | 1.42B | 988.73M | 823.63M | 738.16M |
Balance Sheet | ||||||
| Total Assets | 33.07B | 33.74B | 33.76B | 31.42B | 30.33B | 29.63B |
| Cash, Cash Equivalents and Short-Term Investments | 8.89B | 9.50B | 8.99B | 8.54B | 8.33B | 7.88B |
| Total Debt | 3.34B | 3.84B | 3.83B | 3.61B | 3.60B | 3.81B |
| Total Liabilities | 12.73B | 13.35B | 14.28B | 13.10B | 12.77B | 12.71B |
| Stockholders Equity | 18.27B | 18.30B | 17.50B | 16.48B | 15.83B | 15.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.47B | 1.41B | 666.94M | 968.97M | 712.18M |
| Operating Cash Flow | 0.00 | 2.23B | 2.41B | 1.11B | 1.78B | 1.21B |
| Investing Cash Flow | 0.00 | -993.79M | -1.46B | -443.35M | -684.06M | -568.92M |
| Financing Cash Flow | 0.00 | -730.63M | -492.73M | -454.03M | -630.46M | -509.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥15.77B | 8.02 | ― | 3.89% | -3.00% | -29.83% | |
79 Outperform | ¥60.17B | 11.06 | ― | 2.88% | 3.42% | 13.37% | |
76 Outperform | ¥41.17B | 5.81 | ― | 3.53% | -3.45% | 30.52% | |
74 Outperform | ¥202.44B | 8.69 | ― | 4.09% | 1.69% | 0.94% | |
74 Outperform | ¥2.54T | 14.14 | ― | 1.11% | 2.35% | 0.43% | |
66 Neutral | ¥26.26B | 10.33 | ― | 3.53% | 6.99% | -0.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |